The Appetite for Innovation:

How are payers moving the needle for reimbursement of innovative technologies?

What does it take for emerging technologies to get adopted by payers? The past couple of years have seen some exciting progress, particularly the willingness by the Centers for Medicare and Medicaid to cover telehealth for Medicare Advantage plans. 

The advances in biopharma innovation, particularly gene therapy, will also require payers to step up with bold reimbursement models to ensure proper access to these novel therapies. 

Payers have demonstrated an interest in placing bets of their own with the development of funds to invest in health tech and medtech to meet the needs of their members and address pain points in healthcare overall.

This eBook includes MedCity articles highlighting developments in how payers are addressing these challenges in the short and long term.